CYTO - Altamira stock soars 45% on Bentrio social media postings
2024-05-23 10:00:23 ET
More on Altamira Therapeutics
- Altamira Therapeutics Ltd. 2023 Q4 - Results - Earnings Call Presentation
- Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript
- Altamira reports publication of positive results from NASAR clinical trial with Bentrio
- Altamira stock rallies 44% on Univercells mRNA collaboration
- Seeking Alpha’s Quant Rating on Altamira Therapeutics